ORIGINAL RESEARCH article
Front. Neurol.
Sec. Multiple Sclerosis and Neuroimmunology
Volume 16 - 2025 | doi: 10.3389/fneur.2025.1616245
This article is part of the Research TopicWomen in Multiple Sclerosis and Neuroimmunology: From Bench to BedsideView all 6 articles
Emerging epidemiological trends of multiple sclerosis among adults aged 20-54 years, 1990–2021, with projections to 2035: a systematic analysis for the Global Burden of Disease Study
Provisionally accepted
- 1Department of Neurology, 920th Hospital of the Joint Logistics Support Force, People's Liberation Army, China, kunming, China
- 2The 920th Hospital of Joint Logistics Support Force, Kunming, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background Over recent decades, clinical, scientific, and public awareness of multiple sclerosis (MS) has increased significantly. This study aims to analyze global trends in the incidence, mortality, and disability-adjusted life years (DALYs) of MS among adults aged 20-54 years from 1990 to 2021.Methods Using data from the Global Burden of Disease (GBD) database, this study evaluated MS incidence, mortality, and DALYs in adults aged 20-54 years. Data from 204 countries and territories were stratified by age, sex, and geographical location. Annual percentage changes (APC) were calculated using Joinpoint regression, and estimated annual percentage changes (EAPC) were derived through log-linear regression modeling. Bayesian age-period-cohort (BAPC) modeling was employed to forecast future disease burden. Findings Globally, in 2021, there were 51,904.12 incident MS cases (95% UI, 44,998.80-59,073.37), 4,738.38 deaths (95% UI, 4,492.03-5,024.11), and 512,985.58 DALYs (95% UI, 428,133.20-610,308.62). Between 1990 and 2021, global incidence increased by 49.48% (95% UI, 44.34-55.15%), mortality rose by 18.21% (95% UI, 11.60-25.45%), and DALYs increased by 43.22% (95% UI, 36.79-48.94%). The High SDI region reported the highest rates of incidence (4.38 per 100,000; 95% UI , 3.93-4.83), mortality (0.41 per 100,000; 95% UI, 0.39-0.42), and DALYs (45.00 per 100,000; 95% UI, 37.22-53.12). Regionally, Western Europe had the highest number of cases (10,964.14; 95% UI, 9,572.30-12,318.88). At the national level, the United States reported the most MS incident cases in 2021 (9,388.21; 95% UI, 8,469.23-10,275.59). Sweden had the highest national incidence rate at 10.12 per 100,000 (95% UI, 8.69-11.66), with an EAPC of 0.24 (95% CI, 0.10-0.38).The global incidence, mortality, and DALYs associated with MS have shown increasing trends, although substantial variations persist across different SDI regions. A comprehensive understanding of MS epidemiology is essential for improving global disease prevention and control efforts.
Keywords: Multiple Sclerosis, GBD (2021) database, Incidence, Mortality, DALYs (disability adjusted life year), Public Health
Received: 22 Apr 2025; Accepted: 27 Jun 2025.
Copyright: © 2025 Wang, Wang, Hui, Yang, Liu and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Hang-juan Li, The 920th Hospital of Joint Logistics Support Force, Kunming, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.